CN100337644C - Chinese medicine for treating peptic ulcer and its prepn process - Google Patents
Chinese medicine for treating peptic ulcer and its prepn process Download PDFInfo
- Publication number
- CN100337644C CN100337644C CNB2005100370777A CN200510037077A CN100337644C CN 100337644 C CN100337644 C CN 100337644C CN B2005100370777 A CNB2005100370777 A CN B2005100370777A CN 200510037077 A CN200510037077 A CN 200510037077A CN 100337644 C CN100337644 C CN 100337644C
- Authority
- CN
- China
- Prior art keywords
- powder
- preparation
- chinese patent
- patent medicine
- peptic ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a Chinese patent medicine for treating peptic ulcer, and a preparation method for the Chinese patent medicine. The Chinese patent medicine is prepared by using red ginseng, astragalus root, notoginseng, artificial bezoar and pearl layer powder as raw medicinal materials, and has the effects of replenishing qi, strengthening the spleen, soothing the heart, relieving mental stress, promoting qi to activate blood circulation, relieving inflammation and promoting tissue regeneration. The Chinese patent medicine can be used for treating gastric ulcer, duodenal bulbar ulcer, chronic gastritis, etc.
Description
Technical field
The present invention relates to treat the medicine of peptic ulcer, especially a kind of Chinese patent medicine for the treatment of peptic ulcer and preparation method thereof.
Background technology
Chinese medicine thinks that the pathogenetic reason of ulcer mainly comprises: weakness of the spleen and stomach, and drinking and eating irregularly, feelings will is hindered, pathogen infringement and drug induced injury etc.It is generally acknowledged that human digestive ulcer disease is many because gastric mucosa damage factor (hydrion, bile, medicine etc.) and defence factor (coat of the stomach mucus, closely connect between epithelial cell, the prostaglandin that gastric mucosal blood flow and epithelial cell produce etc.) interaction between, all factors that attack factor enhancing or mucosa defense function are weakened all may become aetiology of Peptic Ulcer; The growth and decline of both sides' strength cause the generation or the healing of ulcer.Drug therapy to Peptic Ulcers is also closely related with this two aspect.Once the someone added up, and about 10% is suffering from peptic ulcer disease in life among the crowd, this shows that peptic ulcer disease is a commonly encountered diseases, frequently-occurring disease.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese patent medicine for the treatment of peptic ulcer and preparation method thereof.
For reaching above-mentioned purpose, a kind of Chinese patent medicine for the treatment of peptic ulcer of the present invention is to be made by following bulk drugs:
Radix Astragali 700-1400 part, red ginseng powder 20-40 part, artificial Calculus Bovis 10-20 part, Radix Notoginseng 70-140 part, Margarita layer powder 100-200 part.
The preferred scheme of the present invention is: the weight portion of described each crude drug is:
756 parts of the Radixs Astragali, 25 parts of red ginseng powders, 13 parts of artificial Calculus Boviss, 76 parts of Radix Notoginseng, 101 parts of Margarita layer powder.
Chinese medicine thinks that the pathogenetic reason of ulcer mainly comprises: weakness of the spleen and stomach, and drinking and eating irregularly, feelings will is hindered, pathogen infringement and drug induced injury etc.The above abdominal pain of Peptic Ulcers is a cardinal symptom, and clinical characters is chronic, periodically and regular epigastrium pain, and is relevant with diet, but the antacid relief of symptoms.Radix Ginseng, Radix Astragali air making-up and spleen enlivening, stomach reinforcing granulation promoting are monarch drug; Radix Notoginseng cooperates ginseng stilbene QI invigorating to promote blood circulation, and the promoting flow of QI and blood pain relieving is a ministerial drug; Artificial Calculus Bovis, Margarita layer powder heat clearing and inflammation relieving, the convergence granulation promoting, relieving gastric hyperacidity to alleviate stomachache, nacreous layer opaque important city, nature and flavor are salty-cold, cooperate with the monarch drug Radix Ginseng, can calm the frightened by mind tranquilizing and the heart calming, and artificial Calculus Bovis, Margarita layer powder two medicines are adjuvant drug altogether.All medicines cooperate, and have the effect of air making-up and spleen enlivening, mind tranquilizing and the heart calming, promoting flow of QI and blood, dephlogistication and promoting nuscle growth, have the gastric abscess that stagnant heat causes concurrently for deficiency-weakness of spleen-QI, have curative effect preferably.
The preparation method of medicine of the present invention comprises the following steps:
A) in the Radix Astragali, red ginseng powder, artificial Calculus Bovis, Radix Notoginseng and Margarita layer powder five tastes medical material, get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
B) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into the 80-120 fine powder, sieves;
C) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder.
The preparation process of various common formulations below is described respectively:
(1) preparation of pill: the medicated powder of obtaining, water is general to be ball, drying, pill is made in the primary colors polishing.
(2) preparation of capsule: the medicated powder of obtaining, the sodium carboxymethyl cellulose of adding 1%, capsule is made in mixing, granulation, filling.
(3) preparation of tablet: the medicated powder of obtaining, admix 0.5% stearic acid, be pressed into tablet.
(4) preparation of granule: the medicated powder of obtaining, add an amount of dextrin, mixing, make granule.
(5) preparation of soft capsule: the medicated powder of obtaining, Polyethylene Glycol-400 and a spot of glycerol of adding equivalent, mixing is pressed into soft capsule.
(6) preparation of powder: the medicated powder of obtaining, directly make powder.
Advantage of the present invention is: it has the effect of air making-up and spleen enlivening, mind tranquilizing and the heart calming, promoting flow of QI and blood, dephlogistication and promoting nuscle growth.Below, the therapeutic effect of preparation of the present invention is described by some experimental datas.
1, the pharmacodynamic experiment result shows:
(1) adopt acidic alcohol, indometacin to cause the acute gastric mucosal lesion model to observe the gastric mucosal protective effect of preparation of the present invention.The acute gastric mucosal lesion MODEL DAMAGE index that preparation of the present invention (0.6g/kg, 1.2g/kg) can make acidic alcohol cause obviously reduces (p＜0.01); Preparation of the present invention (1.2g/kg) can make indometacin cause acute gastric mucosal lesion MODEL DAMAGE index obviously to reduce (p＜0.05).Point out preparation of the present invention that anti-acute gastric mucosal lesion effect is arranged.
Table 1, preparation of the present invention are to the protective effect of acidic alcohol rat pipe film injury
| Group | Dosage (g/kg) | Number of animals (n) | Damage index (x ± s) | Damage incidence rate (%) |
| The big SHIWEISHU of preparation of the present invention in the distilled water group preparation small capital of the present invention invention preparation | Equal-volume water 0.3 0.6 1.2 0.0025 | 12 12 12 12 12 | 73.9±32.3 71.8±34.4 38.1±26.1** 28.9±25.8** 45.5±30.1* | 100 100 91.7 75 83.3 |
Compare with the distilled water group: * P＜0.05; * P＜0.01, below as not special indicate then represent same meaning.
Table 2, preparation of the present invention are to the protective effect of indometacin rat pipe film injury
| Group | Dosage (g/kg) | Number of animals (n) | Damage index (x ± s) | Damage incidence rate (%) |
| The big SHIWEISHU of preparation of the present invention in the distilled water group preparation small capital of the present invention invention preparation | Equal-volume water 0.3 0.6 1.2 0.0025 | 11 12 12 11 12 | 8.50±7.07 8.92±9.13 3.79±4.90 2.77±1.94* 3.01±4.34* | 91.7 83.3 75 91.7 75 |
(2), adopt pylorus ligature law and acetic acid method gastric ulcer model to observe preparation anti-gastric-ulcer of the present invention effect.Preparation of the present invention (1.2g/kg) can make pylorus ligature law rat gastric ulcer index obviously reduce (p＜0.05), and two dosage (0.6g/kg, 1.2g/kg) can make the acetic acid method gastric ulcer rate of closing of fullying recover from an illness obviously improve (p＜0.05 or 0.01).
Table 3, preparation of the present invention are to the preventive effect of rat pylorus ligature law gastric ulcer
| Group | Dosage (g/kg) | Number of animals (n) | Ulcer index (x ± s) | Ulcer incidence rate (%) |
| The big ranitidine of preparation of the present invention in the distilled water group preparation small capital of the present invention invention preparation | Equal-volume water 0.3 0.6 1.2 0.05 | 10 11 11 10 11 | 3.00±0.82 2.36±1.50 2.54±1.44 2.00±1.25* 1.27±1.49** | 100 90.9 100 90 63.6 |
Table 4, preparation of the present invention are to the therapeutical effect of rats acetic acid method gastric ulcer
| Group | Dosage (g/kg) | Number of animals (n) | Ulcer area (mm 2，x±s) | Ulcer healing rate (%) |
| The big ranitidine of preparation of the present invention in the distilled water group preparation small capital of the present invention invention preparation | Equal-volume water 0.3 0.6 1.2 0.05 | 12 11 11 11 11 | 7.13±3.99 4.18±4.69 2.27±4.38** 2.36±2.82** 2.45±3.39** | 0 27.3 72.7** 45.5* 45.5* |
(3), adopt rat Ovum Gallus domesticus album foot swelling method and mouse peritoneal capillary permeability method to observe its anti-acute inflammation effect.The foot swelling rate that preparation group of the present invention (0.6g/kg, 1.2g/kg) causes rat Ovum Gallus domesticus album obviously is less than model group (p＜0.05 or 0.01), and preparation of the present invention (0.6g/kg, 1.2g/kg, 2.4g/kg) can make inflammatory model mouse peritoneal capillary permeability obviously reduce (p＜0.01).Point out preparation of the present invention that anti-acute inflammation effect is arranged.
Table 5, preparation of the present invention are to the effect of rat Ovum Gallus domesticus album foot swelling
| Group | Number of animals (n) | Different time paw swelling behind the albumen injection (%, x ± s) | ||||
| 0.5h | 1h | 2h | 4h | 6h | ||
| The big indometacin of preparation of the present invention in the normal group model group preparation small capital of the present invention invention preparation | 11 10 11 11 11 11 | 4.0±5.0 81.4±16.6 70.0±16.1 61.6±15.2** 57.8±13.6** 57.8±11.1** | 5.7±3.6 82.9±18.6 71.8±16.1 63.8±10.5** 63.9±15.1* 60.5±10.2** | 6.2±2.0 75.6±15.4 72.7±12.9 56.1±14.7** 53.1±14.2** 55.1±12.5** | 5.7±6.8 55.3±15.0 46.1±11.9 49.3±13.2 45.4±16.0 46.6±13.2 | 4.6±3.1 46.0±17.1 41.8±7.0 39.2±10.6 32.±10.7* 32.5±8.2* |
Compare with model group: * P＜0.05; * P＜0.01.
Table 6, preparation of the present invention are to the influence of mouse peritoneal capillary permeability
| Group | Dosage (g/kg) | Number of animals (n) | Absorbance (OD value) (x ± s) |
| The big aspirin compound of preparation of the present invention in the distilled water group preparation small capital of the present invention invention preparation | Equal-volume water 0.6 1.2 2.4 0.21 | 10 11 11 12 11 | 0.136±0.041 0.081±0.035** 0.089±0.031** 0.085±0.044** 0.072±0.022** |
(4), adopt the intestine in vitro exercise test to observe the spasmolysis of preparation of the present invention.The result shows that the tetanic property of the small intestine of guinea pig contraction that isolated small intestines of rabbits that preparation of the present invention causes acetylcholine and histamine cause has tangible antagonism, and its effect is strengthened with the increase of dosage.Point out it that spasmolysis is arranged.
The influence that table 7, preparation of the present invention move to intestine in vitro
| Medicine | Dosage ※ (g/L) | Medicine is caused the tetanic property of small intestinal shrink tension antagonism percentage rate (%) | |
| Acetylcholine | Histamine | ||
| Preparation I of the present invention Formulation II of the present invention Formulation III of the present invention | 4.0 2.0 1.0 | 52.4±22.4(11) 38.7±11.3(9) 16.1±5.7(8) | 97.1±3.9(8) 90.3±12.1(8) 45.1±14.9(8) |
Annotate: number is the intestinal tube number in the bracket.
※For bathing pipe Chinese medicine concentration.
2, carry out clinical observation in The First Affiliated Hospital of Guangzhou University of Traditional Chinese Med, Guangdong Province second institute of traditional Chinese medicine, Guangzhou institute of traditional Chinese medicine, Fujian Institute of Traditional Chinese Medicine.Finish preparation for treating gastric abscess of the present invention clinical research 409 examples altogether, comprise peptic ulcer 265 examples, chronic superficial gastritis 144 examples.Adopt the research method of contrast at random, select ranitidine capsule medicine in contrast for use.Observed result shows: preparation of the present invention has the curative effect of blood stasis pattern of syndrome concurrently and contrasts medicine ranitidine capsule suitable to peptic ulcer and the dialectical weakness of the spleen and stomach that belongs to of chronic superficial gastritis, but improving aspect symptom, the signs such as stomachache degree, stomachache time, seizure frequency, indigestion and loss of appetite, shortness of breath and palpitation, curative effect is better than matched group, and difference has the significance meaning.In the clinical trial process, do not see obvious adverse reaction and malaise symptoms.Illustrate that preparation capsule of the present invention is used effectively clinically, safety.
The specific embodiment
Embodiment 1: the powder preparation method of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining is directly made powder.
Embodiment 2: the pill preparation method of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining, water is general to be ball, drying, pill is made in the primary colors polishing.
Embodiment 3: the capsule preparation method thereof of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining, the sodium carboxymethyl cellulose of adding 1%, capsule is made in mixing, granulation, filling.
Embodiment 4: the method for preparing tablet thereof of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining is admixed 0.5% stearic acid, is pressed into tablet.
Embodiment 5: the process for producing granula of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining adds an amount of dextrin, mixing, makes granule.
Embodiment 6: the soft capsule preparation method of medicine of the present invention:
A) get Radix Astragali 756g, red ginseng powder 25g, artificial Calculus Bovis 13g, Radix Notoginseng 76g, Margarita layer powder 101g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining, Polyethylene Glycol-400 and a spot of glycerol of adding equivalent, mixing is pressed into soft capsule.
Embodiment 7: the pill preparation method of medicine of the present invention:
A) get Radix Astragali 1400g, red ginseng powder 40g, artificial Calculus Bovis 20g, Radix Notoginseng 140g, Margarita layer powder 200g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder that obtains, water is general to be ball, drying, pill is made in the primary colors polishing.
Embodiment 8: the pill preparation method of medicine of the present invention:
A) get Radix Astragali 1100g, red ginseng powder 35g, artificial Calculus Bovis 15g, Radix Notoginseng 100g, Margarita layer powder 150g is standby;
B) get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
C) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into 80-120 order fine powder, sieves;
D) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder;
E) medicated powder of obtaining, water is general to be ball, drying, pill is made in the primary colors polishing.
Claims (10)
1, a kind of Chinese patent medicine for the treatment of peptic ulcer is characterized in that: it is to be made by following bulk drugs: Radix Astragali 700-1400 part, red ginseng powder 20-40 part, artificial Calculus Bovis 10-20 part, Radix Notoginseng 70-140 part, Margarita layer powder 100-200 part.
2, a kind of Chinese patent medicine for the treatment of peptic ulcer as claimed in claim 1, it is characterized in that: the weight portion of described each crude drug is: 756 parts of the Radixs Astragali, 25 parts of red ginseng powders, 13 parts of artificial Calculus Boviss, 76 parts of Radix Notoginseng, 101 parts of Margarita layer powder.
3, a kind of Chinese patent medicine for the treatment of peptic ulcer as claimed in claim 2, it is characterized in that: it can be pill, tablet, capsule, granule, soft capsule or powder.
4, a kind of preparation method for preparing the Chinese patent medicine of the described treatment peptic ulcer of claim 1, it is characterized in that: it comprises the following steps:
A) in the described Radix Astragali, red ginseng powder, artificial Calculus Bovis, Radix Notoginseng and the Margarita layer powder five tastes medical material, get the Radix Astragali and decoct with water twice, 3 hours for the first time, 2 hours for the second time, filter, merging filtrate is condensed into thick paste;
B) thick paste and red ginseng powder, Radix Notoginseng powder, the Margarita layer powder mix homogeneously, drying is ground into the 80-120 fine powder, sieves;
C) add the artificial Calculus Bovis with the facing-up method, mix homogeneously obtains medicated powder.
5, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, water is general to be ball, drying, and pill is made in the primary colors polishing.
6, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, add 1% sodium carboxymethyl cellulose, capsule is made in mixing, granulation, filling.
7, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, admix 0.5% stearic acid, be pressed into tablet.
8, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, add an amount of dextrin, mixing, make granule.
9, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, add Polyethylene Glycol-400 and a spot of glycerol of equivalent, mixing is pressed into soft capsule.
10, a kind of preparation method for the treatment of the Chinese patent medicine of peptic ulcer as claimed in claim 4 is characterized in that: get gained medicated powder, make powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100370777A CN100337644C (en) | 2005-09-08 | 2005-09-08 | Chinese medicine for treating peptic ulcer and its prepn process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100370777A CN100337644C (en) | 2005-09-08 | 2005-09-08 | Chinese medicine for treating peptic ulcer and its prepn process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739615A CN1739615A (en) | 2006-03-01 |
| CN100337644C true CN100337644C (en) | 2007-09-19 |
Family
ID=36092240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100370777A Active CN100337644C (en) | 2005-09-08 | 2005-09-08 | Chinese medicine for treating peptic ulcer and its prepn process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100337644C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102078369A (en) * | 2011-01-20 | 2011-06-01 | 广州中一药业有限公司 | Application of Chinese patent drug for treating peptic ulcer in preparing alcohol resistance medicament |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103565906B (en) * | 2012-07-30 | 2016-01-20 | 广州白云山中一药业有限公司 | Chinese patent medicine for the treatment of peptic ulcer and preparation method thereof |
| CN102772670B (en) * | 2012-08-17 | 2013-08-21 | 张守实 | Traditional Chinese medicine composition for treating superficial gastritis |
-
2005
- 2005-09-08 CN CNB2005100370777A patent/CN100337644C/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 中华人民共和国卫生部药品标准第16册 中华人民共和国卫生部药典委员会，121 1998 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102078369A (en) * | 2011-01-20 | 2011-06-01 | 广州中一药业有限公司 | Application of Chinese patent drug for treating peptic ulcer in preparing alcohol resistance medicament |
| CN102078369B (en) * | 2011-01-20 | 2012-06-06 | 广州中一药业有限公司 | Application of Chinese patent drug for treating peptic ulcer in preparing alcohol resistance medicament |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1739615A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1739734A (en) | Chinese medicine prepn for treating stomatitis and its prepn process | |
| CN1785367A (en) | Medicine for trenting flooding and spotting, haematemesis and homafecia | |
| CN100337644C (en) | Chinese medicine for treating peptic ulcer and its prepn process | |
| CN1861184A (en) | Application of composition for preparing medicine to treat chilblain disease | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN1069042C (en) | Use of cajanus cajan medicine | |
| CN1284585C (en) | Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method | |
| CN101028488A (en) | Chinese medicine for chronic pharyngitis, esophagus inflammation and esophagus cancer | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN1706467A (en) | Plaster for treating bronchitis | |
| CN1276764C (en) | Liu-Wei-Bu-Xue granule for invigorating blood contg. six herbal medicines and its prepn. method | |
| CN1943700A (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN1907452A (en) | Medicine for treating chronic colitis and its preparing process | |
| CN1475261A (en) | Medicine for treating gastral cavity pain and its preparation method | |
| CN1283277C (en) | Medicinal formula of calculus bovis cold-clearing capsule | |
| CN1785410A (en) | Preparation method of ready prepared chinese medicinal granules for treathing pains | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN1259949C (en) | Capsule for treating wound | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN1282610A (en) | Medicine for treating gastrointestinal diseases and its preparing process | |
| CN1273174C (en) | Gastrosis treating medicine | |
| CN1112204C (en) | Traditional Chinese powder medicine for treating cough and preparation process thereof | |
| CN1068523C (en) | Medicine for treating cancer and its preparing technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: GUANGZHOU BAIYUNSHAN ZHONGYI PHARMACEUTICAL CO., L Free format text: FORMER NAME: GUANGZHOU ZHONGYI PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 510530, No. 32, Po pan Road, Guangzhou, Guangdong, Luogang District Patentee after: Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. Address before: 11, building 510620, west block, Times Square, 28 Tianhe North Road, Guangzhou, Guangdong Patentee before: Guangzhou Zhongyi Pharmaceutical Co., Ltd. |